Hypertrophic Cardiomyopathy (HCM): Clinical Trials

1 trial for Hypertrophic Cardiomyopathy (HCM), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Hypertrophic Cardiomyopathy (HCM): new trials by email Literature Review of Hypertrophic Cardiomyopathy (HCM) trials Research Report on Hypertrophic Cardiomyopathy (HCM)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
Anticoagulant treatment Rivaroxaban, Best medical therapy - Hypertrophic Cardiomyopathy (HCM)
Phase 3RecruitingRennes University Hospital5322026-01-072026-06-12

Narrower conditions

Cardiomyopathy, Hypertrophic (1)

Broader conditions

Aortic Stenosis, Subvalvular (1)  ·  Aortic Valve Disease (1)  ·  Aortic Valve Stenosis (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Heart Valve Diseases (1)

Sponsors

Rennes University Hospital (1)

Countries

France (1)

Top investigators

Donal Erwan (1)